Table 2 Treatments groups
Group | Treatment regimen | Treatment | Tablets per day |
|---|---|---|---|
1 | 2 mg BI 425809 QD | 1 mg | 2-0-0 |
25 mg PTM | 1-0-0 | ||
2 | 5 mg BI 425809 QD | 5 mg | 1-0-0 |
1 and 5 mg PTM | 1-0-0 | ||
25 mg PTM | 1-0-0 | ||
3 | 10 mg BI 425809 QD | 5 mg | 2-0-0 |
25 mg PTM | 1-0-0 | ||
4 | 25 mg BI 425809 QD | 1 and 5 mg PTM | 2-0-0 |
25 mg | 1-0-0 | ||
5 | Placebo QD | 1 and 5 mg PTM | 2-0-0 |
25 mg PTM | 1-0-0 |